Understanding this connection reveals why medications addressing weight may produce unexpected psychological benefits
Among other things, there can be no guarantee that future study results will be consistent with the results to date, that Zepbound will receive additional regulatory approvals, that Zepbound will be commercially successful, or that Lilly will execute its strategy as planned
The Semaglutide cohort compared to the non-GLP-1RA anti-diabetes medications cohort included more women, had a higher prevalence of problems with lifestyle, obesity, obesity-associated comorbidities, mental disorders, and substance use disorders
GPR119 expression in normal human tissues and islet cell tumors: evidence for its islet-gastrointestinal distribution, expression in pancreatic beta and alpha cells, and involvement in islet function
Most people lose between 15% and 20% of their starting body weight when using Ozempic consistently